Doğuş GYO Valuation Multiples

Doğuş GYO is valued at $188M as of September 2026, a 11.4x revenue multiple. In the last fiscal year, Doğuş GYO revenue was $24M and Doğuş GYO EBITDA was $14M.

Doğuş GYO Overview

About Doğuş GYO

DOGUS Gayrimenkul Yatirim Ortakligi AS is a real estate investment trust based in Turkey. The company has operations in the residential, commercial and Retail sectors. Its portfolio comprises of Dogus Center Maslak, Dogus Center Etiler, Gebze Center Shopping Center, Gebze Center- Hotel and Gebze Center - Automotive Showroom and Service.


Founded

1997

HQ

Turkey

Employees

10

Financials (Last FY)

Revenue: $24M
EBITDA: $14M

EV

$268M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Doğuş GYO Financials

Doğuş GYO reported last fiscal year revenue of $24M and EBITDA of $14M.

In the same fiscal year, Doğuş GYO generated $20M in gross profit, $14M in EBITDA, and had net loss of ($5M).


Doğuş GYO P&L

In the most recent fiscal year, Doğuş GYO reported revenue of $24M and EBITDA of $14M.

Doğuş GYO is unprofitable as of last fiscal year, with gross margin of 84%, EBITDA margin of 60%, and net margin of (20%).

See analyst estimates for Doğuş GYO
Last FY2025202620272028
Revenue$24M$24M
Gross Profit$20M$20M
Gross Margin84%84%
EBITDA$14M$14M
EBITDA Margin60%60%
EBIT Margin74%74%
Net Profit($5M)($5M)
Net Margin(20%)(20%)
Net Debt$65M-

Financial data powered by Morningstar, Inc.

Doğuş GYO Stock Performance

Doğuş GYO has current market cap of $188M, and enterprise value of $268M.


Doğuş GYO's stock price is $0.57.

Doğuş GYO has an EPS (earnings per share) of $-0.01.

See more trading valuation data for Doğuş GYO
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$268M$188M-4.3%---$-0.01

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Doğuş GYO Valuation Multiples

Doğuş GYO trades at 11.4x EV/Revenue multiple, and 19.2x EV/EBITDA.

See NTM and 2027E valuation multiples for Doğuş GYO

Doğuş GYO Financial Valuation Multiples

As of September 22, 2026, Doğuş GYO has market cap of $188M and EV of $268M.

Doğuş GYO has a P/E ratio of (39.0x).

Last FY2025202620272028
EV/Revenue11.4x11.4x
EV/EBITDA19.2x19.2x
EV/EBIT15.3x15.3x
EV/Gross Profit13.6x13.6x
P/E(39.0x)(39.0x)
EV/FCF24.9x24.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Doğuş GYO Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Doğuş GYO Margins & Growth Rates

In the most recent fiscal year, Doğuş GYO reported gross margin of 84%, EBITDA margin of 60%, and net margin of (20%).

See estimated margins and future growth rates for Doğuş GYO

Doğuş GYO Margins

Last FY2025202720282029
Gross Margin84%84%
EBITDA Margin60%60%
EBIT Margin74%74%
Net Margin(20%)(20%)
FCF Margin46%46%

Data powered by FactSet, Inc. and Morningstar, Inc.

Doğuş GYO Operational KPIs

Doğuş GYO's revenue per employee in the last FY averaged $2.4M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for Doğuş GYO
Last FY2025202620272028
Revenue per Employee$2.4M-
Opex per Employee$0.2M-
G&A Expenses to Revenue1%1%
Opex to Revenue9%9%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Doğuş GYO Competitors

Doğuş GYO competitors include Akfen GYO, Akmerkez GYO, Grupo Gicsa, Vakıf GYO, Koray GYO, Garda Property, Panora GYO, Servet GYO, 029 Group and Btsp II FII.

Most Doğuş GYO public comparables operate across Buildings & Property.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Akfen GYO$34M-8.9x---
Akmerkez GYO$23M$18M7.0x-8.9x-
Grupo Gicsa$348M$307M5.5x6.0x6.2x9.2x
Vakıf GYO$55M$38M2.8x-4.1x-
Koray GYO$9M($22M)28.7x-(11.1x)-
Garda Property$14M$8M12.3x7.6x22.7x8.2x
Panora GYO$23M-9.5x---
Servet GYO$83M$60M4.5x-6.2x-

This data is available for Pro users. Sign up to see all Doğuş GYO competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Doğuş GYO

When was Doğuş GYO founded?Doğuş GYO was founded in 1997.
Where is Doğuş GYO headquartered?Doğuş GYO is headquartered in Turkey.
How many employees does Doğuş GYO have?As of today, Doğuş GYO has over 10 employees.
Is Doğuş GYO publicly listed?Yes, Doğuş GYO is a public company listed on Borsa Istanbul.
What is the stock symbol of Doğuş GYO?Doğuş GYO trades under DGGYO ticker.
When did Doğuş GYO go public?Doğuş GYO went public in 2000.
Who are competitors of Doğuş GYO?Doğuş GYO main competitors include Akfen GYO, Akmerkez GYO, Grupo Gicsa, Vakıf GYO, Koray GYO, Garda Property, Panora GYO, Servet GYO, 029 Group, Btsp II FII.
What is the current market cap of Doğuş GYO?Doğuş GYO's current market cap is $188M.
What is the current revenue of Doğuş GYO?Doğuş GYO's last fiscal year revenue is $24M.
What is the current EV/Revenue multiple of Doğuş GYO?Current revenue multiple of Doğuş GYO is 11.4x.
Is Doğuş GYO profitable?No, Doğuş GYO is not profitable.
How many companies Doğuş GYO has acquired to date?Doğuş GYO hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Doğuş GYO has invested to date?Doğuş GYO hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Doğuş GYO

Lists including Doğuş GYO

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial